Meitav Investment House’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-111,610	Closed	-$8.14M	–	391
2018 Q4	$8.14M	Sell	111,610 -90	-0.1%	-$6.56K	0.5%	57
2018 Q3	$10.1M	Buy	111,700 +56,700	+103%	+$5.11M	0.49%	53
2018 Q2	$5.41M	Buy	+55,000	New	+$5.41M	0.24%	77